Benign Evolution of Complex Regional Pain Syndrome (CRPS) Type 1 in Patients Treated with Intravenous Neridronate: A Single-Center Real-Life Experience
Our real-life data indicate that early treatment with neridronate leads to substantial benefits in patients affected by CRPS type 1. The strongest responses are seen in young patients, males, and those with lower limb involvement.
Authors
- Lucia Lisi (ORCID: https://orcid.org/0000-0003-1397-2426)
- Federica Pignatti
- Lisa Berti (ORCID: https://orcid.org/0000-0002-0840-6617)
- Piero Ruscitti (ORCID: https://orcid.org/0000-0003-3487-8551)
- Francesco Ursini (ORCID: https://orcid.org/0000-0001-8194-8642)
- Claudio Ripamonti (ORCID: https://orcid.org/0000-0001-6066-3808)
- Jacopo Ciaffi (ORCID: https://orcid.org/0000-0002-9446-7351)
- Gianluca Festuccia (ORCID: https://orcid.org/0000-0003-4849-5666)
- Veronica Brusi (ORCID: https://orcid.org/0000-0002-2973-4484)
- Luana Mancarella (ORCID: https://orcid.org/0000-0002-8229-2443)
- Cesare Faldini (ORCID: https://orcid.org/0000-0001-8152-4778)
Institutions
- University of L'Aquila (IT)
- Istituto Ortopedico Rizzoli (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Bologna (IT)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2024-11-08
- DOI
- https://doi.org/10.3390/ph17111500
- Primary Topic
- Pain Management and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00